Richard A. Larson to Hydroxamic Acids
This is a "connection" page, showing publications Richard A. Larson has written about Hydroxamic Acids.
Connection Strength
0.122
-
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia. Invest New Drugs. 2015 Apr; 33(2):371-9.
Score: 0.122